Market Cap 191.74M
Revenue (ttm) 112.82M
Net Income (ttm) -10.88M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -9.64%
Debt to Equity Ratio 0.00
Volume 59,700
Avg Vol 109,886
Day's Range N/A - N/A
Shares Out 13.31M
Stochastic %K 50%
Beta 0.23
Analysts Strong Sell
Price Target $17.50

Company Profile

Anika Therapeutics, Inc., a joint preservation company, focuses on early intervention orthopedics in the United States, Europe, and internationally. The company offers osteoarthritis (OA) pain management products and services, such as Monovisc and Orthovisc, which are single- and multi-injection, HA viscosupplement products indicated for pain relief from OA conditions, as well as Cingal, a non-opioid, single-injection OA pain management product; regenerative solutions, including an HA-based scaf...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 781 457 9000
Fax: 781 305 9720
Address:
32 Wiggins Avenue, Bedford, United States
Doozio
Doozio May. 26 at 11:19 PM
$ANIK gap still controls da pattern an a RARE 4/29 Wed 🐑 now out of the tightness it was always ONTO 🐒🍌🧠⏰♾️
0 · Reply
NVDAMillionaire
NVDAMillionaire May. 13 at 9:05 PM
$ANIK Outstanding article that hits the mark on ANIK's current state. So if you want to refresh your ANIK insights or learn about ANIK from scratch, this is a must read. https://everyticker.com/quote/ANIK/analysis/anika-therapeutics-ha-pure-play-turnaround-gains-momentum-as-margins-recover-and-commercial-channel-accelerates-nasdaq-anik
0 · Reply
BillionerOfKing
BillionerOfKing May. 11 at 5:37 PM
$ANIK Current Stock Price: $14.43 Contracts to trade: $15.0 ANIK May 15 2026 Call Entry: $0.22 Exit: $0.35 ROI: 62% Hold ~24 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
PenkeInvesting
PenkeInvesting May. 2 at 2:56 AM
Fundamental analysis of $ANIK (Anika Therapeutics, Inc.) based on financial data and reported results. #ANIK #Anika
0 · Reply
Mookdog1964
Mookdog1964 May. 1 at 4:57 PM
$ANIK i double down in this one , who is selling this 😂 Margin expansion , no debt , new drug growing , pipeline is solid ha ! ok you sell , i will buy your shares
0 · Reply
G101SPM
G101SPM May. 1 at 1:45 PM
#OPTIONACTION $ANIK Chief Executive Officer bought 12,200 shares at $12.235 - $12.30 worth approximately $150K (transaction date 4/30). BWMX Chief Executive Officer bought 10,000 Ordinary Shares worth approximately $168K (transaction date 4/28). $GEHC President / Chief Executive Officer and General Counsel & Corporate Secretary bought 5,919 shares combined worth approximately $356K (transaction dates were 4/30). $TEN Chief Executive Officer bought 25,000 shares at $39.43 - $40.35 worth approximately $998K (transaction dates 4/28-4/29). $CAR EVP, Chief HR Officer and EVP, CDIO sold 12,952 shares combined worth approxima
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Apr. 30 at 11:25 PM
$ANIK CEO purchased 12,200 shares at $12.29 for a total of $149,881. Griffin Stephen D. now owns 36,163 shares. https://ceo-buys.com
0 · Reply
FilingTracker
FilingTracker Apr. 30 at 9:24 PM
$ANIK President and CEO purchased additional shares: https://www.sec.gov/Archives/edgar/data/898437/000119312526197887/xslF345X06/ownership.xml
0 · Reply
Estimize
Estimize Apr. 29 at 11:01 PM
$ANIK reported 0.27 EPS and 29.61 revenue for Q1. http://www.estimize.com/intro/anik?chart=historical&metric_name=eps&utm_content=ANIK&utm_
0 · Reply
Arcides
Arcides Apr. 29 at 6:00 PM
$ANIK love for bios is over
0 · Reply
Latest News on ANIK
Anika Therapeutics Proxy statement: Proxy filing

Jun 1, 2026, 8:00 AM EDT - 4 days ago

Anika Therapeutics Proxy statement: Proxy filing


Anika Therapeutics reports Q1 EPS 27c vs.(6c) last year

2026-04-29T13:24:55.000Z - 5 weeks ago

Anika Therapeutics reports Q1 EPS 27c vs.(6c) last year


Anika Therapeutics Earnings Call Transcript: Q1 2026

Apr 29, 2026, 8:30 AM EDT - 5 weeks ago

Anika Therapeutics Earnings Call Transcript: Q1 2026


Anika Therapeutics Earnings release: Q1 2026

Apr 29, 2026, 8:30 AM EDT - 5 weeks ago

Anika Therapeutics Earnings release: Q1 2026


Anika Therapeutics Slides: Q1 2026

Apr 29, 2026, 8:30 AM EDT - 5 weeks ago

Anika Therapeutics Slides: Q1 2026


Anika Therapeutics Quarterly report: Q1 2026

Apr 29, 2026, 8:30 AM EDT - 5 weeks ago

Anika Therapeutics Quarterly report: Q1 2026


Anika Reports First Quarter 2026 Financial Results

Apr 29, 2026, 7:05 AM EDT - 5 weeks ago

Anika Reports First Quarter 2026 Financial Results


Anika Therapeutics Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 5 weeks ago

Anika Therapeutics Proxy statement: Proxy filing


Anika Therapeutics Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 5 weeks ago

Anika Therapeutics Proxy statement: Proxy filing


Anika Therapeutics Slides: FY 2026

Mar 2, 2026, 12:30 PM EST - 3 months ago

Anika Therapeutics Slides: FY 2026


Anika Therapeutics Earnings Call Transcript: Q4 2025

Feb 26, 2026, 8:30 AM EST - 3 months ago

Anika Therapeutics Earnings Call Transcript: Q4 2025


Anika Therapeutics Annual report: Q4 2025

Feb 26, 2026, 8:30 AM EST - 3 months ago

Anika Therapeutics Annual report: Q4 2025


Anika Therapeutics Earnings release: Q4 2025

Feb 26, 2026, 8:30 AM EST - 3 months ago

Anika Therapeutics Earnings release: Q4 2025


Anika Therapeutics Slides: Q4 2025

Feb 26, 2026, 8:30 AM EST - 3 months ago

Anika Therapeutics Slides: Q4 2025


Anika Therapeutics reports Q4 EPS 31c vs (3c) last year

2026-02-26T12:27:46.000Z - 3 months ago

Anika Therapeutics reports Q4 EPS 31c vs (3c) last year


Anika Therapeutics sees FY26 revenue $114M-$122.5M

2026-02-26T12:26:54.000Z - 3 months ago

Anika Therapeutics sees FY26 revenue $114M-$122.5M


Anika Therapeutics Earnings Call Transcript: Q3 2025

Nov 5, 2025, 8:30 AM EST - 7 months ago

Anika Therapeutics Earnings Call Transcript: Q3 2025


Anika Therapeutics Quarterly report: Q3 2025

Nov 5, 2025, 8:30 AM EST - 7 months ago

Anika Therapeutics Quarterly report: Q3 2025


Anika Therapeutics Earnings release: Q3 2025

Nov 5, 2025, 8:30 AM EST - 7 months ago

Anika Therapeutics Earnings release: Q3 2025


Anika Therapeutics Slides: Q3 2025

Nov 5, 2025, 8:30 AM EST - 7 months ago

Anika Therapeutics Slides: Q3 2025


Anika Therapeutics reaffirms FY25 guidance

2025-11-05T12:33:05.000Z - 7 months ago

Anika Therapeutics reaffirms FY25 guidance


Anika Therapeutics commences $15M 10b5-1 share repurchase

2025-11-05T12:32:46.000Z - 7 months ago

Anika Therapeutics commences $15M 10b5-1 share repurchase


Anika Therapeutics reports Q3 adjusted EPS 4c vs. 7c last year

2025-11-05T12:25:20.000Z - 7 months ago

Anika Therapeutics reports Q3 adjusted EPS 4c vs. 7c last year


Anika Reports Third Quarter 2025 Financial Results

Nov 5, 2025, 7:05 AM EST - 7 months ago

Anika Reports Third Quarter 2025 Financial Results


Anika Therapeutics Earnings Call Transcript: Q2 2025

Jul 30, 2025, 8:30 AM EDT - 11 months ago

Anika Therapeutics Earnings Call Transcript: Q2 2025


Anika Therapeutics Quarterly report: Q2 2025

Jul 30, 2025, 8:30 AM EDT - 11 months ago

Anika Therapeutics Quarterly report: Q2 2025


Anika Therapeutics Earnings release: Q2 2025

Jul 30, 2025, 8:30 AM EDT - 11 months ago

Anika Therapeutics Earnings release: Q2 2025


Anika Therapeutics Slides: Q2 2025

Jul 30, 2025, 8:30 AM EDT - 11 months ago

Anika Therapeutics Slides: Q2 2025


Anika Therapeutics reports Q2 adjusted EPS (13c) vs 4c last year

2025-07-30T11:16:54.000Z - 11 months ago

Anika Therapeutics reports Q2 adjusted EPS (13c) vs 4c last year


Anika Reports Second Quarter 2025 Financial Results

Jul 30, 2025, 7:05 AM EDT - 11 months ago

Anika Reports Second Quarter 2025 Financial Results


Anika Therapeutics Earnings Call Transcript: Q1 2025

May 9, 2025, 8:30 AM EDT - 1 year ago

Anika Therapeutics Earnings Call Transcript: Q1 2025


Anika Therapeutics Quarterly report: Q1 2025

May 9, 2025, 8:30 AM EDT - 1 year ago

Anika Therapeutics Quarterly report: Q1 2025


Anika Therapeutics Earnings release: Q1 2025

May 9, 2025, 8:30 AM EDT - 1 year ago

Anika Therapeutics Earnings release: Q1 2025


Anika Therapeutics Slides: Q1 2025

May 9, 2025, 8:30 AM EDT - 1 year ago

Anika Therapeutics Slides: Q1 2025


Anika Reports First Quarter 2025 Financial Results

May 9, 2025, 7:05 AM EDT - 1 year ago

Anika Reports First Quarter 2025 Financial Results


Anika Therapeutics Proxy statement: Proxy Filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Anika Therapeutics Proxy statement: Proxy Filing


Anika Therapeutics Proxy statement: Proxy Filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Anika Therapeutics Proxy statement: Proxy Filing


Anika Therapeutics Earnings Call Transcript: Q4 2024

Mar 12, 2025, 5:00 PM EDT - 1 year ago

Anika Therapeutics Earnings Call Transcript: Q4 2024


Anika Therapeutics Annual report: Q4 2024

Mar 12, 2025, 5:00 PM EDT - 1 year ago

Anika Therapeutics Annual report: Q4 2024


Anika Therapeutics Earnings release: Q4 2024

Mar 12, 2025, 5:00 PM EDT - 1 year ago

Anika Therapeutics Earnings release: Q4 2024


Anika Therapeutics Slides: Q4 2024

Mar 12, 2025, 5:00 PM EDT - 1 year ago

Anika Therapeutics Slides: Q4 2024


Anika Completes Divestiture of Parcus Medical

Mar 7, 2025, 6:00 AM EST - 1 year ago

Anika Completes Divestiture of Parcus Medical


Anika To Participate in December 2024 Investor Conferences

Nov 22, 2024, 4:16 PM EST - 1 year ago

Anika To Participate in December 2024 Investor Conferences


Anika Therapeutics Earnings Call Transcript: Q3 2024

Oct 31, 2024, 8:30 AM EDT - 1 year ago

Anika Therapeutics Earnings Call Transcript: Q3 2024


Anika Therapeutics Quarterly report: Q3 2024

Oct 31, 2024, 8:30 AM EDT - 1 year ago

Anika Therapeutics Quarterly report: Q3 2024


Anika Therapeutics Earnings release: Q3 2024

Oct 31, 2024, 8:30 AM EDT - 1 year ago

Anika Therapeutics Earnings release: Q3 2024


Anika Therapeutics Slides: Q3 2024

Oct 31, 2024, 8:30 AM EDT - 1 year ago

Anika Therapeutics Slides: Q3 2024


Anika Reports Third Quarter 2024 Financial Results

Oct 31, 2024, 7:05 AM EDT - 1 year ago

Anika Reports Third Quarter 2024 Financial Results


Anika Therapeutics Earnings Call Transcript: Q2 2024

Aug 8, 2024, 5:00 PM EDT - 1 year ago

Anika Therapeutics Earnings Call Transcript: Q2 2024


Anika Therapeutics Quarterly report: Q2 2024

Aug 8, 2024, 5:00 PM EDT - 1 year ago

Anika Therapeutics Quarterly report: Q2 2024


Anika Therapeutics Earnings release: Q2 2024

Aug 8, 2024, 5:00 PM EDT - 1 year ago

Anika Therapeutics Earnings release: Q2 2024


Anika Therapeutics Slides: Q2 2024

Aug 8, 2024, 5:00 PM EDT - 1 year ago

Anika Therapeutics Slides: Q2 2024


Anika Reports Second Quarter 2024 Financial Results

Aug 8, 2024, 4:05 PM EDT - 1 year ago

Anika Reports Second Quarter 2024 Financial Results


Anika Therapeutics Proxy statement: Proxy Filing

Jun 25, 2024, 8:00 AM EDT - 2 years ago

Anika Therapeutics Proxy statement: Proxy Filing


Anika Therapeutics Proxy statement: Proxy Filing

Jun 11, 2024, 8:00 AM EDT - 2 years ago

Anika Therapeutics Proxy statement: Proxy Filing


Anika Enters into Cooperation Agreement with Caligan Partners

May 28, 2024, 4:05 PM EDT - 2 years ago

Anika Enters into Cooperation Agreement with Caligan Partners


Anika Therapeutics Earnings Call Transcript: Q1 2024

May 8, 2024, 5:30 PM EDT - 2 years ago

Anika Therapeutics Earnings Call Transcript: Q1 2024


Anika Therapeutics Quarterly report: Q1 2024

May 8, 2024, 5:30 PM EDT - 2 years ago

Anika Therapeutics Quarterly report: Q1 2024


Anika Therapeutics Earnings release: Q1 2024

May 8, 2024, 5:30 PM EDT - 2 years ago

Anika Therapeutics Earnings release: Q1 2024


Anika Therapeutics Slides: Q1 2024

May 8, 2024, 5:30 PM EDT - 2 years ago

Anika Therapeutics Slides: Q1 2024


Anika Announces CFO Transition

May 8, 2024, 4:08 PM EDT - 2 years ago

Anika Announces CFO Transition


Anika Reports First Quarter 2024 Financial Results

May 8, 2024, 4:05 PM EDT - 2 years ago

Anika Reports First Quarter 2024 Financial Results


Anika Therapeutics Earnings Call Transcript: Q4 2023

Mar 13, 2024, 5:00 PM EDT - 2 years ago

Anika Therapeutics Earnings Call Transcript: Q4 2023


Anika Therapeutics Annual report: Q4 2023

Mar 13, 2024, 5:00 PM EDT - 2 years ago

Anika Therapeutics Annual report: Q4 2023


Anika Therapeutics Earnings release: Q4 2023

Mar 13, 2024, 5:00 PM EDT - 2 years ago

Anika Therapeutics Earnings release: Q4 2023


Anika Therapeutics Slides: Q4 2023

Mar 13, 2024, 5:00 PM EDT - 2 years ago

Anika Therapeutics Slides: Q4 2023


Doozio
Doozio May. 26 at 11:19 PM
$ANIK gap still controls da pattern an a RARE 4/29 Wed 🐑 now out of the tightness it was always ONTO 🐒🍌🧠⏰♾️
0 · Reply
NVDAMillionaire
NVDAMillionaire May. 13 at 9:05 PM
$ANIK Outstanding article that hits the mark on ANIK's current state. So if you want to refresh your ANIK insights or learn about ANIK from scratch, this is a must read. https://everyticker.com/quote/ANIK/analysis/anika-therapeutics-ha-pure-play-turnaround-gains-momentum-as-margins-recover-and-commercial-channel-accelerates-nasdaq-anik
0 · Reply
BillionerOfKing
BillionerOfKing May. 11 at 5:37 PM
$ANIK Current Stock Price: $14.43 Contracts to trade: $15.0 ANIK May 15 2026 Call Entry: $0.22 Exit: $0.35 ROI: 62% Hold ~24 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
PenkeInvesting
PenkeInvesting May. 2 at 2:56 AM
Fundamental analysis of $ANIK (Anika Therapeutics, Inc.) based on financial data and reported results. #ANIK #Anika
0 · Reply
Mookdog1964
Mookdog1964 May. 1 at 4:57 PM
$ANIK i double down in this one , who is selling this 😂 Margin expansion , no debt , new drug growing , pipeline is solid ha ! ok you sell , i will buy your shares
0 · Reply
G101SPM
G101SPM May. 1 at 1:45 PM
#OPTIONACTION $ANIK Chief Executive Officer bought 12,200 shares at $12.235 - $12.30 worth approximately $150K (transaction date 4/30). BWMX Chief Executive Officer bought 10,000 Ordinary Shares worth approximately $168K (transaction date 4/28). $GEHC President / Chief Executive Officer and General Counsel & Corporate Secretary bought 5,919 shares combined worth approximately $356K (transaction dates were 4/30). $TEN Chief Executive Officer bought 25,000 shares at $39.43 - $40.35 worth approximately $998K (transaction dates 4/28-4/29). $CAR EVP, Chief HR Officer and EVP, CDIO sold 12,952 shares combined worth approxima
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Apr. 30 at 11:25 PM
$ANIK CEO purchased 12,200 shares at $12.29 for a total of $149,881. Griffin Stephen D. now owns 36,163 shares. https://ceo-buys.com
0 · Reply
FilingTracker
FilingTracker Apr. 30 at 9:24 PM
$ANIK President and CEO purchased additional shares: https://www.sec.gov/Archives/edgar/data/898437/000119312526197887/xslF345X06/ownership.xml
0 · Reply
Estimize
Estimize Apr. 29 at 11:01 PM
$ANIK reported 0.27 EPS and 29.61 revenue for Q1. http://www.estimize.com/intro/anik?chart=historical&metric_name=eps&utm_content=ANIK&utm_
0 · Reply
Arcides
Arcides Apr. 29 at 6:00 PM
$ANIK love for bios is over
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Apr. 29 at 11:27 AM
$ANIK Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.37 down -32.14% YoY • Reported revenue of $29.61M up 13.16% YoY • Anika Therapeutics Inc. expects full year 2024 total revenue to be in the range of $162 million to $168 million, and adjusted EBITDA to be between $10 million and $15 million.
0 · Reply
Estimize
Estimize Apr. 21 at 11:06 PM
Wall St is expecting -0.07 EPS for $ANIK Q1 [Reporting 04/29 BMO] http://www.estimize.com/intro/anik?chart=historical&metric_name=eps&utm_c
0 · Reply
focafoca99
focafoca99 Apr. 6 at 1:51 AM
$ANIK issued a small inducement grant, with 3,138 RSUs awarded to one newly hired non-executive employee.
0 · Reply
Doozio
Doozio Apr. 4 at 7:15 PM
2/26 eps gap n go an Jon $ANIK is back ENTA 🐒🍌🧠⏰♾️
0 · Reply
SuperGreenToday
SuperGreenToday Mar. 26 at 5:49 PM
$ANIK Share Price: $14.89 Contract Selected: Sep 18, 2026 $12.5 Calls Buy Zone: $0.42 – $0.53 Target Zone: $0.77 – $0.94 Potential Upside: 71% ROI Time to Expiration: 175 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
NYBomba
NYBomba Mar. 11 at 2:00 PM
$ANIK - great long term hold, don’t ignore its 63% 5 yr growth plus buyback plus institutions hold 92% of the float… its sales against CAP makes it dirt cheap plus add its Golden Cross happened just 2 weeks ago💥💥💥☮️
0 · Reply
BillionerOfKing
BillionerOfKing Mar. 3 at 6:28 PM
$ANIK Current Stock Price: $14.18 Contracts to trade: $15.0 ANIK Mar 20 2026 Call Entry: $0.05 Exit: $0.07 ROI: 50% Hold ~31 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 26 at 12:25 PM
$ANIK Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $0.13 up 176.47% YoY • Reported revenue of $30.61M up 2473.26% YoY • Anika expects 2026 total company revenue between $114M and $122.5M, representing a 1% to 9% year-over-year increase. Adjusted EBITDA as a percent of revenue is guided to 5% to 10%.
0 · Reply
SuperGreenToday
SuperGreenToday Feb. 18 at 1:39 AM
$ANIK Share Price: $10.42 Contract Selected: Sep 18, 2026 $5 Calls Buy Zone: $2.98 – $3.68 Target Zone: $4.84 – $5.92 Potential Upside: 54% ROI Time to Expiration: 212 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply